Pédiatrie Sarcomes
COTESARC (pédiatrie)
multicentre, open-label, Phase I-II study evaluating the combination of a MEK inhibitor and a PDL1 inhibitor in pediatric and adult patients with locally advanced and/or metastatic soft tissue sarcoma
Paris
ISABELLE AERTS